Skip to main content
Equibles
MGRX logo

MGRX · Mangoceuticals, Inc.

Track MGRX — free

Use MGRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.40 -0.01 (-1.72%) At close · Aug 31
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the ability of the Company to continue as a going concern. Unless management is able to obtain additional financing, it is unlikely that the Company will be able to meet its funding requirements during the 12 months from the date of issuance of this filing.”
View the 10-Q filed Aug 13, 2026
Market Cap
$8.67M
Shares
21.57M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.40 Open$0.39 Day$0.39–0.42 52W close$0.16–2.74 Avg vol 30d26.7M Short int1.8M · 8.4% float · 1.0d Short vol41% DataOct 2024–Aug 2026 Filing10-Q · Aug 13

Raw chart and full-history price indicators begin at the captured split on Oct 16, 2024; bars on opposite sides are not compared.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 13, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Neutral Sentiment Bullish Fundamentals Fair Quant / Vol Very High
Market backdrop VIX 14.9 · calm Equity put/call 0.62
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −27%
below
Price vs 50-day avg −8%
below
RSI (14) 45
neutral
MACD trend Negative
52-week position 9%
near low
Momentum
relative strength
Neutral
1-month return −28%
trailing
6-month return +16%
trailing
YTD return −46%
this year
Relative strength +2%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.40% of float · ▼ -3.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
18 holders — near 3-yr high, broad support
Squeeze score 52
elevated · 0–100
Fundamentals
Fair
Revenue growth −26%
Y/Y
Gross margin 55%
contracting
EPS growth +55%
Y/Y
Free cash flow $-5.9M
Quant / Vol
risk profile
Very High
Volatility 215%
annualized · 1-yr
Max drawdown −94%
past year
ATR 20.5%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−27% Bearish
Price vs 50-day avg
−8% Bearish
RSI (14)
45 Neutral
MACD trend
Negative Bearish
52-week position
9% Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $0 › 200d $1 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
8.40% of float · ▼ -3.7% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
18 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $0 Now $0 · 9% Range high $3
vs 200-day avg -27% vs 50-day avg -8%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Health Information Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
MGRX
Mangoceuticals, Inc.
this stock
$8.67M -45.6% -26.0% — 8.4%
VEEV
Veeva Systems Inc
 $44.80B +23.9% +28.1% 45.3 3.6%
PMDIY
Pro Medicus Ltd./ADR
 $13.02B -24.9% — — 0.0%
BTSG
BrightSpring Health Services, Inc.
 $11.56B +55.9% +28.2% 35.4 4.5%
TEM
Tempus AI, Inc.
 $11.56B +8.5% +83.4% — 16.6%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
18
% held
5.6%
Net QoQ
+374.3K sh
Top holder
CITADEL ADVISORS LLC
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Falling
Shares short
1.8M
Days to cover
1.0d
Change
-69.5K sh
View
Short Volume
Short vol %
41%
As of
Aug 31, 2026
Short Total
View
Fails to Deliver
FTD shares
291.4K
Value
$154.5K
As of
Aug 14, 2026
View
Off-Exchange
Off-exchange %
71.9%
Week of
Jul 27, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$456.0K
Net income (FY)
$-20.6M
EPS diluted
$-2.17
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 21, 2026
This year
11
View
Proposed Sales
Value
$148.9K
Shares
128.3K
Filed
Dec 3, 2025
View
Exempt Offerings
Offering
$2.0M
Filed
Oct 11, 2022
View

Performance

Raw-price comparisons begin at the captured split on Oct 16, 2024; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
MGRX -4.7% -27.8% +15.9% -27.8% -45.7%
SPY +0.5% +3.0% +13.4% +3.0% +12.8%
vs SPY -5.2% -30.8% +2.5% -30.8% -58.5%
Key facts CIK 1938046 CUSIP 56270V205 13F (30d) 15 filings 15 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)